GLP-1 糖尿病内科

Sir Andrew Witty, CEO of GSK said, “It is patients’ interests thatalways come first."

投稿日:21/12/2013 更新日:

GlaxoSmithKline (GSK) said they will stop paying their sales reps based on the number of prescriptions they persuade doctors to write.

Why do they stop paying?

Sir Andrew Witty, CEO of GSK said:“We believe that it is imperative that we continue to actively challenge our business model at every level to ensure we are responding to the needs of patients and meeting the wider expectations of society. Over the past five years, this has seen us take significant steps to increase access to medicines in developing countries and to be more transparent with our clinical trial data. We’ve also made changes to how we work with healthcare professionals. Building on this, today we are outlining a further set of measures to modernise our relationship with healthcare professionals. These are designed to bring greater clarity and confidence that whenever we talk to a doctor, nurse or other prescriber, it is patients’ interests that always come first. We recognise that we have an important role to play in providing doctors with information about our medicines, but this must be done clearly, transparently and without any perception of conflict of interest.”

He is a man of noble mind to say such a thing.
I Look up to him as a mentor.

Frankly speaking, MRs of GSK are not appropriate for my patients’ interests.
So I made up my mind to modernise my relationship with them. In oredr to bring greater clarity and confidence, I will never, for the life of me, meet them again.

It is patients’ interests that always come first.

-GLP-1, 糖尿病内科

Copyright© 船橋市の糖尿病専門クリニック , 2018 All Rights Reserved.